These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25107509)

  • 1. Factors influencing malaria control policy-making in Kenya, Uganda and Tanzania.
    Mutero CM; Kramer RA; Paul C; Lesser A; Miranda ML; Mboera LE; Kiptui R; Kabatereine N; Ameneshewa B
    Malar J; 2014 Aug; 13():305. PubMed ID: 25107509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated vector management for malaria control in Uganda: knowledge, perceptions and policy development.
    Mutero CM; Schlodder D; Kabatereine N; Kramer R
    Malar J; 2012 Jan; 11():21. PubMed ID: 22243516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying barriers in the malaria control policymaking process in East Africa: insights from stakeholders and a structured literature review.
    Paul C; Kramer R; Lesser A; Mutero C; Miranda ML; Dickinson K
    BMC Public Health; 2015 Sep; 15():862. PubMed ID: 26341406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opinions of key stakeholders on alternative interventions for malaria control and elimination in Tanzania.
    Finda MF; Christofides N; Lezaun J; Tarimo B; Chaki P; Kelly AH; Kapologwe N; Kazyoba P; Emidi B; Okumu FO
    Malar J; 2020 Apr; 19(1):164. PubMed ID: 32321534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania.
    Romore I; Njau RJ; Semali I; Mwisongo A; Ba Nguz A; Mshinda H; Tanner M; Abdulla S
    Malar J; 2016 Mar; 15():143. PubMed ID: 26956944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
    Mubyazi GM; Gonzalez-Block MA
    Malar J; 2005 Oct; 4():51. PubMed ID: 16242017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.
    Ladner J; Davis B; Audureau E; Saba J
    Malar J; 2017 Aug; 16(1):353. PubMed ID: 28851358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using decision analysis to improve malaria control policy making.
    Kramer RA; Dickinson KL; Anderson RM; Fowler VG; Miranda ML; Mutero CM; Saterson KA; Wiener JB
    Health Policy; 2009 Oct; 92(2-3):133-40. PubMed ID: 19356821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulating the council-specific impact of anti-malaria interventions: A tool to support malaria strategic planning in Tanzania.
    Runge M; Snow RW; Molteni F; Thawer S; Mohamed A; Mandike R; Giorgi E; Macharia PM; Smith TA; Lengeler C; Pothin E
    PLoS One; 2020; 15(2):e0228469. PubMed ID: 32074112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
    Amin AA; Zurovac D; Kangwana BB; Greenfield J; Otieno DN; Akhwale WS; Snow RW
    Malar J; 2007 May; 6():72. PubMed ID: 17535417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles and influence of actors in the uptake of evidence: the case of malaria treatment policy change in Uganda.
    Nabyonga-Orem J; Nanyunja M; Marchal B; Criel B; Ssengooba F
    Implement Sci; 2014 Oct; 9():150. PubMed ID: 25294279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applied mathematical modelling to inform national malaria policies, strategies and operations in Tanzania.
    Runge M; Molteni F; Mandike R; Snow RW; Lengeler C; Mohamed A; Pothin E
    Malar J; 2020 Mar; 19(1):101. PubMed ID: 32122342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria treatment policy change in Uganda: what role did evidence play?
    Nabyonga-Orem J; Ssengooba F; Macq J; Criel B
    Malar J; 2014 Sep; 13():345. PubMed ID: 25179532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power and Agenda-Setting in Tanzanian Health Policy: An Analysis of Stakeholder Perspectives.
    Fischer SE; Strandberg-Larsen M
    Int J Health Policy Manag; 2016 Feb; 5(6):355-63. PubMed ID: 27285513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National malaria vector control policy: an analysis of the decision to scale-up larviciding in Nigeria.
    Tesfazghi K; Hill J; Jones C; Ranson H; Worrall E
    Health Policy Plan; 2016 Feb; 31(1):91-101. PubMed ID: 26082391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National medicines regulatory authorities financial sustainability in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
    PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy development in malaria vector management in Mozambique, South Africa and Zimbabwe.
    Cliff J; Lewin S; Woelk G; Fernandes B; Mariano A; Sevene E; Daniels K; Matinhure S; Oxman A; Lavis J
    Health Policy Plan; 2010 Sep; 25(5):372-83. PubMed ID: 20176574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis.
    Behzadifar M; Gorji HA; Rezapour A; Rezvanian A; Bragazzi NL; Vatankhah S
    Health Res Policy Syst; 2019 Apr; 17(1):42. PubMed ID: 30992014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consolidating tactical planning and implementation frameworks for integrated vector management in Uganda.
    Okia M; Okui P; Lugemwa M; Govere JM; Katamba V; Rwakimari JB; Mpeka B; Chanda E
    Malar J; 2016 Apr; 15():214. PubMed ID: 27074809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The process of changing national malaria treatment policy: lessons from country-level studies.
    Williams HA; Durrheim D; Shretta R
    Health Policy Plan; 2004 Nov; 19(6):356-70. PubMed ID: 15459161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.